Cary F. Opel

Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses

Kelly D. Moynihan, Cary F. Opel, Gregory L. Szeto et al. · Nature Medicine · 2016 · 527 citations · Full text

Immune Evasion, Tumor Immunology, Cancer Immunosurveillance +15

Biopolymers codelivering engineered T cells and STING agonists can eliminate heterogeneous tumors

Tyrel T. Smith, Howell Moffett, Sirkka B. Stephan et al. · Journal of Clinical Investigation · 2017 · 329 citations · Full text

Engineering, Immunology, Immunoediting +23

Synergistic Innate and Adaptive Immune Response to Combination Immunotherapy with Anti-Tumor Antigen Antibodies and Extended Serum Half-Life IL-2

Eric Zhu, S. Annie Gai, Cary F. Opel et al. · Cancer Cell · 2015 · 179 citations · Full text

Tumor Immunology, Cancer Immunosurveillance, Autoimmune Disease +14

Antigen specificity can be irrelevant to immunocytokine efficacy and biodistribution

Alice Tzeng, Byron H. Kwan, Cary F. Opel et al. · Proceedings of the National Academy of Sciences · 2015 · 117 citations · Full text

Quantitative modeling of viable cell density, cell size, intracellular conductivity, and membrane capacitance in batch and fed‐batch CHO processes using dielectric spectroscopy

Cary F. Opel, Jincai Li, Ashraf Amanullah · Biotechnology Progress · 2010 · 110 citations

Cell Size, Dielectric Spectroscopy, Engineering +15